A development stage pharmaceutical company engaged in the discovery, development and commercialization of carbohydrate-based therapeutic compounds for advanced treatment of cancer, liver, microbial, cardiovascular and inflammatory diseases.



Stock Performance

GALT vs. S&P 500 | 2 Year Performance
View Interactive GALT Charts
Sponsored by

Key Data Points

Primary metrics and data points about Galectin Therapeutics.
Current Price: $1.64
Prev Close: $1.57
Open: $1.54
Bid: $1.40
Ask: $1.67
Day's Range: $1.54 - $1.66
52wk Range: $1.08 - $3.33
Volume: 273,102
Avg Vol 67,116
Market Cap: $39.24M
P/E (ttm): -1.74
EPS (ttm): -$0.90
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Galectin Therapeutics.
CAPS Rating 1 out of 5
 
47 Outperform
38 Underperform
CAPS All Stars
 
3 Outperform
25 Underperform

How do you think Galectin Therapeutics will perform against the market?



You pick for Galectin Therapeutics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Galectin Therapeutics.

A development stage pharmaceutical company engaged in the discovery, development and commercialization of carbohydrate-based therapeutic compounds for advanced treatment of cancer, liver, microbial, cardiovascular and inflammatory diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers